安科生物：2025年半年度净利润约3.67亿元

Core Viewpoint - Anke Biological reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [2] Financial Performance - The company's revenue for the first half of 2025 was approximately 1.292 billion yuan, a year-on-year decrease of 0.51% [2] - The net profit attributable to shareholders was around 367 million yuan, reflecting a year-on-year decline of 11.92% [2] - Basic earnings per share were 0.2191 yuan, down 11.72% compared to the previous year [2]